PetMed Express (PETS) Stock Forecast, Price Target & Predictions
PETS Stock Forecast
PetMed Express stock forecast is as follows: an average price target of $11.00 (represents a 162.53% upside from PETS’s last price of $4.19) and a rating consensus of 'Hold', based on 2 wall street analysts offering a 1-year stock forecast.
PETS Price Target
The average price target for PetMed Express (PETS) is $11.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $19.00 to $7.00. This represents a potential 162.53% upside from PETS's last price of $4.19.
PETS Analyst Ratings
According to 2 Wall Street analysts, PetMed Express's rating consensus is 'Hold'. The analyst rating breakdown for PETS stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 1 'Hold' (50.00%), 1 'Sell' (50.00%), and 0 'Strong Sell' (0.00%).
PetMed Express Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jun 12, 2024 | Ryan Meyers | Lake Street | $7.00 | $4.13 | 69.29% | 67.06% |
| Jun 12, 2024 | Ryan Meyers | Loop Capital Markets | $7.00 | $4.13 | 69.70% | 67.06% |
| Jul 26, 2022 | - | Morgan Stanley | $19.00 | $20.25 | -6.17% | 353.46% |
| May 10, 2022 | - | Morgan Stanley | $20.00 | $22.22 | -9.99% | 377.33% |
The latest PetMed Express stock forecast, released on Jun 12, 2024 by Ryan Meyers from Lake Street, set a price target of $7.00, which represents a 69.29% increase from the stock price at the time of the forecast ($4.13), and a 67.06% increase from PETS last price ($4.19).
PetMed Express Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $7.00 |
| Last Closing Price | $4.19 | $4.19 | $4.19 |
| Upside/Downside | -100.00% | -100.00% | 67.06% |
In the current month, the average price target of PetMed Express stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to PetMed Express's last price of $4.19. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 07, 2024 | Lake Street | Buy | Hold | Downgrade |
| Jun 12, 2024 | Lake Street | Buy | Buy | Hold |
| Jul 26, 2022 | Morgan Stanley | Underweight | Underweight | Hold |
| May 10, 2022 | Morgan Stanley | Underweight | Underweight | Hold |
PetMed Express's last stock rating was published by Lake Street on Aug 07, 2024. The company Downgrade its PETS rating from "Buy" to "Hold".
PetMed Express Financial Forecast
PetMed Express Revenue Forecast
| Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | $121.94M | $78.24M | $62.41M | $58.87M | $65.39M | $70.19M | $66.00M | $60.72M | $67.39M | $79.31M | $71.68M | $65.90M | $75.44M | $96.20M | $74.29M | $59.91M | $69.94M | $79.99M | $64.56M | $67.32M |
| Avg Forecast | $68.20M | $65.70M | $66.70M | $68.60M | $67.50M | $65.00M | $66.00M | $75.00M | $65.00M | $65.00M | $76.00M | $79.95M | $65.75M | $62.03M | $65.40M | $78.25M | $68.25M | $64.11M | $70.96M | $87.73M | $76.39M | $64.29M | $77.90M | $88.32M | $66.24M | $61.45M | $69.65M | $85.83M | $69.06M | $63.28M |
| High Forecast | $68.20M | $65.70M | $66.70M | $68.60M | $67.50M | $65.00M | $66.00M | $75.00M | $65.00M | $65.00M | $76.00M | $79.95M | $65.75M | $62.03M | $65.40M | $78.25M | $68.25M | $64.11M | $70.96M | $87.73M | $76.39M | $64.29M | $77.90M | $88.32M | $66.24M | $61.45M | $69.65M | $85.83M | $69.06M | $75.94M |
| Low Forecast | $68.20M | $65.70M | $66.70M | $68.60M | $67.50M | $65.00M | $66.00M | $75.00M | $65.00M | $65.00M | $76.00M | $79.95M | $65.75M | $62.03M | $65.40M | $78.25M | $68.25M | $64.11M | $70.96M | $87.73M | $76.39M | $64.29M | $77.90M | $88.32M | $66.24M | $61.45M | $69.65M | $85.83M | $69.06M | $50.62M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 | 3 | 7 | 9 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 1.60% | 0.98% | 0.95% | 0.95% | 1.00% | 0.90% | 0.97% | 0.95% | 0.95% | 0.90% | 0.94% | 1.02% | 0.97% | 1.09% | 1.12% | 0.98% | 1.00% | 0.93% | 0.93% | 1.06% |
PetMed Express's average Quarter revenue forecast for Dec 23 based on 1 analysts is $65.00M, with a low forecast of $65.00M, and a high forecast of $65.00M. PETS's average Quarter revenue forecast represents a -46.69% decrease compared to the company's last Quarter revenue of $121.94M (Sep 23).
PetMed Express EBITDA Forecast
| Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 | 3 | 7 | 9 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | $2.10M | $-450.00K | $-6.12M | $172.00K | $3.82M | $4.24M | $7.74M | $6.23M | $9.03M | $6.43M | $9.48M | $10.33M | $11.48M | $10.34M | $9.68M | $9.22M | $9.71M | $7.55M | $9.17M | $15.02M |
| Avg Forecast | $4.90M | $4.72M | $4.79M | $4.93M | $4.85M | $4.67M | $4.74M | $5.38M | $9.67M | $4.67M | $5.46M | $5.74M | $8.79M | $8.91M | $4.70M | $5.62M | $6.95M | $4.60M | $5.10M | $6.30M | $10.91M | $4.62M | $5.59M | $6.34M | $7.67M | $4.41M | $5.00M | $6.16M | $11.96M | $14.06M |
| High Forecast | $4.90M | $4.72M | $4.79M | $4.93M | $4.85M | $4.67M | $4.74M | $5.38M | $11.60M | $4.67M | $5.46M | $5.74M | $10.55M | $10.69M | $4.70M | $5.62M | $8.34M | $4.60M | $5.10M | $6.30M | $13.09M | $4.62M | $5.59M | $6.34M | $9.21M | $4.41M | $5.00M | $6.16M | $14.35M | $16.87M |
| Low Forecast | $4.90M | $4.72M | $4.79M | $4.93M | $4.85M | $4.67M | $4.74M | $5.38M | $7.74M | $4.67M | $5.46M | $5.74M | $7.03M | $7.12M | $4.70M | $5.62M | $5.56M | $4.60M | $5.10M | $6.30M | $8.73M | $4.62M | $5.59M | $6.34M | $6.14M | $4.41M | $5.00M | $6.16M | $9.57M | $11.25M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.38% | -0.08% | -0.70% | 0.02% | 0.81% | 0.76% | 1.11% | 1.35% | 1.77% | 1.02% | 0.87% | 2.24% | 2.05% | 1.63% | 1.26% | 2.09% | 1.94% | 1.23% | 0.77% | 1.07% |
1 analysts predict PETS's average Quarter EBITDA for Dec 23 to be $4.67M, with a high of $4.67M and a low of $4.67M. This is 122.66% upper than PetMed Express's previous annual EBITDA (Sep 23) of $2.10M.
PetMed Express Net Income Forecast
| Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 | 3 | 7 | 9 |
| Net Income | - | - | - | - | - | - | - | - | - | - | $-70.00K | $-887.00K | $-5.10M | $-19.00K | $2.58M | $2.77M | $6.07M | $4.26M | $6.35M | $4.43M | $6.81M | $7.61M | $8.41M | $7.77M | $7.00M | $6.84M | $6.67M | $5.34M | $6.62M | $10.18M |
| Avg Forecast | $418.83K | $-942.37K | $-523.54K | $-837.66K | $-523.54K | $-209.41K | $-1.15M | $-1.88M | $7.14M | $-209.41K | $1.78M | $1.54M | $6.49M | $6.09M | $5.24M | $5.31M | $5.13M | $6.28M | $7.26M | $7.75M | $7.83M | $8.10M | $8.49M | $8.10M | $5.55M | $6.28M | $5.44M | $8.87M | $8.63M | $9.53M |
| High Forecast | $418.83K | $-942.37K | $-523.54K | $-837.66K | $-523.54K | $-209.41K | $-1.15M | $-1.88M | $8.57M | $-209.41K | $1.78M | $1.54M | $7.79M | $7.31M | $5.24M | $5.31M | $6.16M | $6.28M | $7.26M | $7.75M | $9.40M | $8.10M | $8.49M | $8.10M | $6.66M | $6.28M | $5.44M | $8.87M | $10.36M | $11.44M |
| Low Forecast | $418.83K | $-942.37K | $-523.54K | $-837.66K | $-523.54K | $-209.41K | $-1.15M | $-1.88M | $5.71M | $-209.41K | $1.78M | $1.54M | $5.19M | $4.87M | $5.24M | $5.31M | $4.11M | $6.28M | $7.26M | $7.75M | $6.27M | $8.10M | $8.49M | $8.10M | $4.44M | $6.28M | $5.44M | $8.87M | $6.91M | $7.63M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | -0.04% | -0.58% | -0.79% | -0.00% | 0.49% | 0.52% | 1.18% | 0.68% | 0.87% | 0.57% | 0.87% | 0.94% | 0.99% | 0.96% | 1.26% | 1.09% | 1.22% | 0.60% | 0.77% | 1.07% |
PetMed Express's average Quarter net income forecast for Dec 22 is $6.09M, with a range of $4.87M to $7.31M. PETS's average Quarter net income forecast represents a 136.04% increase compared to the company's last Quarter net income of $2.58M (Sep 22).
PetMed Express SG&A Forecast
| Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 | 3 | 7 | 9 |
| SG&A | - | - | - | - | - | - | - | - | - | - | $18.79M | $22.98M | $23.50M | $15.07M | $14.63M | $15.70M | $11.65M | $11.87M | $10.39M | $15.71M | $11.50M | $9.71M | $11.94M | $16.79M | $12.62M | $9.20M | $11.06M | $15.13M | $12.36M | $10.38M |
| Avg Forecast | $14.45M | $13.92M | $14.14M | $14.54M | $14.31M | $13.78M | $13.99M | $15.90M | $13.72M | $13.78M | $16.11M | $16.94M | $12.47M | $16.97M | $13.86M | $16.58M | $9.86M | $13.59M | $15.04M | $18.59M | $13.22M | $13.63M | $16.51M | $18.72M | $10.01M | $13.02M | $14.76M | $18.19M | $16.12M | $9.72M |
| High Forecast | $14.45M | $13.92M | $14.14M | $14.54M | $14.31M | $13.78M | $13.99M | $15.90M | $16.46M | $13.78M | $16.11M | $16.94M | $14.97M | $20.37M | $13.86M | $16.58M | $11.83M | $13.59M | $15.04M | $18.59M | $15.87M | $13.63M | $16.51M | $18.72M | $12.01M | $13.02M | $14.76M | $18.19M | $19.35M | $11.66M |
| Low Forecast | $14.45M | $13.92M | $14.14M | $14.54M | $14.31M | $13.78M | $13.99M | $15.90M | $10.98M | $13.78M | $16.11M | $16.94M | $9.98M | $13.58M | $13.86M | $16.58M | $7.89M | $13.59M | $15.04M | $18.59M | $10.58M | $13.63M | $16.51M | $18.72M | $8.01M | $13.02M | $14.76M | $18.19M | $12.90M | $7.77M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 1.17% | 1.36% | 1.88% | 0.89% | 1.06% | 0.95% | 1.18% | 0.87% | 0.69% | 0.85% | 0.87% | 0.71% | 0.72% | 0.90% | 1.26% | 0.71% | 0.75% | 0.83% | 0.77% | 1.07% |
PetMed Express's average Quarter SG&A projection for Dec 23 is $13.78M, based on 1 Wall Street analysts, with a range of $13.78M to $13.78M. The forecast indicates a -26.68% fall compared to PETS last annual SG&A of $18.79M (Sep 23).
PetMed Express EPS Forecast
| Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 | 3 | 7 | 9 |
| EPS | - | - | - | - | - | - | - | - | - | - | $-0.00 | $-0.04 | $-0.25 | $-0.00 | $0.13 | $0.14 | $0.30 | $0.21 | $0.31 | $0.22 | $0.34 | $0.38 | $0.42 | $0.39 | $0.35 | $0.34 | $0.33 | $0.26 | $0.32 | $0.50 |
| Avg Forecast | $0.02 | $-0.04 | $-0.03 | $-0.04 | $-0.03 | $-0.01 | $-0.06 | $-0.09 | $-0.07 | $-0.01 | $0.09 | $0.07 | $0.14 | $0.20 | $0.25 | $0.25 | $0.27 | $0.30 | $0.35 | $0.37 | $0.41 | $0.39 | $0.41 | $0.39 | $0.29 | $0.30 | $0.26 | $0.42 | $0.46 | $0.44 |
| High Forecast | $0.02 | $-0.04 | $-0.03 | $-0.04 | $-0.03 | $-0.01 | $-0.06 | $-0.09 | $-0.07 | $-0.01 | $0.09 | $0.07 | $0.14 | $0.20 | $0.25 | $0.25 | $0.27 | $0.30 | $0.35 | $0.37 | $0.41 | $0.39 | $0.41 | $0.39 | $0.29 | $0.30 | $0.26 | $0.42 | $0.46 | $0.53 |
| Low Forecast | $0.02 | $-0.04 | $-0.03 | $-0.04 | $-0.03 | $-0.01 | $-0.06 | $-0.09 | $-0.07 | $-0.01 | $0.09 | $0.07 | $0.14 | $0.20 | $0.25 | $0.25 | $0.27 | $0.30 | $0.35 | $0.37 | $0.41 | $0.39 | $0.41 | $0.39 | $0.29 | $0.30 | $0.26 | $0.42 | $0.46 | $0.35 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | -0.04% | -0.59% | -1.83% | -0.00% | 0.52% | 0.55% | 1.11% | 0.70% | 0.89% | 0.59% | 0.83% | 0.98% | 1.04% | 1.01% | 1.20% | 1.13% | 1.27% | 0.61% | 0.69% | 1.14% |
According to 1 Wall Street analysts, PetMed Express's projected average Quarter EPS for Dec 22 is $0.20, with a low estimate of $0.20 and a high estimate of $0.20. This represents a 51.28% increase compared to PETS previous annual EPS of $0.13 (Sep 22).
PETS Forecast FAQ
Is PetMed Express a good buy?
No, according to 2 Wall Street analysts, PetMed Express (PETS) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 0 'Buy' recommendations, accounting for 0% of PETS's total ratings.
What is PETS's price target?
PetMed Express (PETS) average price target is $11 with a range of $7 to $19, implying a 162.53% from its last price of $4.19. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will PetMed Express stock go up soon?
According to Wall Street analysts' prediction for PETS stock, the company can go up by 162.53% (from the last price of $4.19 to the average price target of $11), up by 353.46% based on the highest stock price target, and up by 67.06% based on the lowest stock price target.
Can PetMed Express stock reach $6?
PETS's average twelve months analyst stock price target of $11 supports the claim that PetMed Express can reach $6 in the near future.
What are PetMed Express's analysts' financial forecasts?
PetMed Express's analysts financial forecasts for the fiscal year (Mar 2025) are as follows: average revenue is $273.5M (high $273.5M, low $273.5M), average EBITDA is $19.64M (high $19.64M, low $19.64M), average net income is $-3.769M (high $-3.769M, low $-3.769M), average SG&A $57.97M (high $57.97M, low $57.97M), and average EPS is $-0.18 (high $-0.18, low $-0.18). PETS's analysts financial forecasts for the fiscal year (Mar 2026) are as follows: average revenue is $269.2M (high $269.2M, low $269.2M), average EBITDA is $19.33M (high $19.33M, low $19.33M), average net income is $-1.885M (high $-1.885M, low $-1.885M), average SG&A $57.05M (high $57.05M, low $57.05M), and average EPS is $-0.09 (high $-0.09, low $-0.09).
Did the PETS's actual financial results beat the analysts' financial forecasts?
Based on PetMed Express's last annual report (Mar 2023), the company's revenue was $256.86M, which missed the average analysts forecast of $271.43M by -5.37%. Apple's EBITDA was $2.12M, missing the average prediction of $28.01M by -92.45%. The company's net income was $233K, missing the average estimation of $23.12M by -98.99%. Apple's SG&A was $68.9M, beating the average forecast of $59.89M by 15.04%. Lastly, the company's EPS was $0.01, missing the average prediction of $0.837 by -98.80%. In terms of the last quarterly report (Sep 2023), PetMed Express's revenue was $121.94M, beating the average analysts' forecast of $76M by 60.44%. The company's EBITDA was $2.1M, missing the average prediction of $5.46M by -61.59%. PetMed Express's net income was $-70K, missing the average estimation of $1.78M by -103.93%. The company's SG&A was $18.79M, beating the average forecast of $16.11M by 16.65%. Lastly, the company's EPS was $-0.0034, missing the average prediction of $0.085 by -104.00%